COSMOS Pharmaceutical Corp.

48
Sell
  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: JP3298400007
  • TKS: 3349
JPY
6,436.00
-207 (-3.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
May'26
May'25
May'24
May'23
May'22
May'21
No of Months
12
12
12
12
12
12
Operating Income
10,99,583.00
10,11,390.00
9,64,989.00
8,27,697.00
7,55,414.00
7,26,424.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
10,99,583.00
10,11,390.00
9,64,989.00
8,27,697.00
7,55,414.00
7,26,424.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
581.00
254.00
99.00
51.00
52.00
60.00
General and Administration Expenses
1,64,687.00
1,72,877.00
1,38,536.00
1,22,807.00
1,07,756.00
99,163.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
10,57,230.00
9,70,986.00
9,33,487.00
7,97,568.00
7,25,617.00
6,93,277.00
Operating Profit (PBDIT) excl Other Income
42,353.00
40,404.00
31,502.00
30,129.00
29,797.00
33,147.00
Other Income
2,610.00
2,500.00
2,497.00
2,894.00
3,313.00
6,957.00
Operating Profit (PBDIT)
69,539.00
65,133.00
53,923.00
50,391.00
48,220.00
53,889.00
Interest
581.00
254.00
99.00
51.00
52.00
60.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
24,576.00
22,229.00
19,924.00
17,368.00
15,110.00
13,785.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
44,218.00
42,372.00
33,719.00
32,773.00
33,048.00
38,596.00
Provision for Tax
12,171.00
11,393.00
9,265.00
8,975.00
9,892.00
11,439.00
Profit After Tax
32,046.00
30,978.00
24,454.00
23,797.00
23,155.00
27,156.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
404.33
390.85
308.61
300.48
292.37
342.89
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2026 is 8.72% vs 4.81% in May 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2026 is 4.82% vs 28.26% in May 2025

stock-summary

Interest

YoY Growth in year ended May 2026 is 128.74% vs 156.57% in May 2025

stock-summary

Profit After Tax

YoY Growth in year ended May 2026 is 3.45% vs 26.68% in May 2025

Compare Profit and Loss Results of COSMOS Pharmaceutical Corp.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
10,99,583.00
12,85,005.00
-1,85,422.00
-14.43%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10,99,583.00
12,85,005.00
-1,85,422.00
-14.43%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
581.00
785.00
-204.00
-25.99%
General and Administration Expenses
1,64,687.00
3,28,008.00
-1,63,321.00
-49.79%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
10,57,230.00
12,48,595.00
-1,91,365.00
-15.33%
Operating Profit (PBDIT) excl Other Income
42,353.00
36,410.00
5,943.00
16.32%
Other Income
2,610.00
5,077.00
-2,467.00
-48.59%
Operating Profit (PBDIT)
69,539.00
67,735.00
1,804.00
2.66%
Interest
581.00
785.00
-204.00
-25.99%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
24,576.00
26,248.00
-1,672.00
-6.37%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
44,218.00
26,277.00
17,941.00
68.28%
Provision for Tax
12,171.00
11,938.00
233.00
1.95%
Profit After Tax
32,046.00
14,957.00
17,089.00
114.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
404.3288
72.1751
332.15
460.21%
Profit And Loss - Net Sales
Net Sales 10,99,583.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 8.72% vs 4.81% in May 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42,353.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 4.82% vs 28.26% in May 2025

Profit And Loss - Interest
Interest 581.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 128.74% vs 156.57% in May 2025

Profit And Loss - Profit After Tax
Profit After Tax 32,046.00 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 3.45% vs 26.68% in May 2025

Footer loading